Access update by Simon Collins, HIV i-Base
On 9 September 2026, the National Institute for Health and Care Excellence (NICE) announced in a 28-page report, that a ground-breaking six-monthly injection, with close to 100% efficacy against HIV transmission, will not be available in England for people at high risk.
In December 2025, lenacapavir was approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) as being both safe and effective as PrEP for the prevention of HIV-1 in adults and adolescents, but without NICE approval, access on the NHS England remains blocked.
Read more here.
Source : HIV i-Base
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.